Similar articles

• Miscellaneous treatments, II: niacin and heparin: unapproved uses, dosages, or indications.

  Wolf R, Orion E, Matz H, Tüzün Y, Tüzün B. Wolf R, et al. Clin Dermatol. 2002 Sep-Oct;20(5):547-57. doi: 10.1016/s0738-081x(02)00268-7. Clin Dermatol. 2002. PMID: 12435525 Review. No abstract available.
• Photodynamic therapy: unapproved uses, dosages, or indications.

  Salva KA. Salva KA. Clin Dermatol. 2002 Sep-Oct;20(5):571-81. doi: 10.1016/s0738-081x(02)00266-3. Clin Dermatol. 2002. PMID: 12435528 Review. No abstract available.
• Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications.

  Koo JY, Ng TC. Koo JY, et al. Clin Dermatol. 2002 Sep-Oct;20(5):582-94. doi: 10.1016/s0738-081x(02)00267-5. Clin Dermatol. 2002. PMID: 12435529 Review. No abstract available.
• Topical corticosteroids: unapproved uses, dosages, or indications.

  Lagos BR, Maibach HI. Lagos BR, et al. Clin Dermatol. 2002 Sep-Oct;20(5):490-2. doi: 10.1016/s0738-081x(02)00279-1. Clin Dermatol. 2002. PMID: 12435519 Review. No abstract available.
• New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.

  Assmann T, Ruzicka T. Assmann T, et al. Clin Dermatol. 2002 Sep-Oct;20(5):505-14. doi: 10.1016/s0738-081x(02)00271-7. Clin Dermatol. 2002. PMID: 12435521 Review. No abstract available.